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Autophagy was initially characterized as a process to digest cellular components, 
including damaged cell organelles or unused proteins. However, later studies showed 
that autophagy plays an important role to protect hosts from microbial infections. 
Accumulating evidences showed the contribution of autophagy itself and autophagy- 
related proteins (ATGs) in the clearance of bacteria, virus, and parasites. A number of 
studies also revealed the molecular mechanisms by which autophagy is initiated and 
developed. Furthermore, it is now understood that some ATGs are shared between 
two distinct processes; autophagy and LC3-associated phagocytosis (LAP). Thus, our 
understanding on autophagy has been greatly enhanced in the last decade. By con-
trast, roles of autophagy and ATGs in fungal infections are still elusive relative to those 
in bacterial and viral infections. Based on limited numbers of reports, ATG-mediated 
host responses appear to significantly vary depending on invading fungal species. In 
this review, we discuss how autophagy and ATGs are involved in antifungal immune 
responses based on recent discoveries.
Keywords: autophagy, LC3-associated phagocytosis, fungal infection, phagocytosis, macrophages, Candida, 
Cryptococcus, Aspergillus
HOST iMMUniTY AGAinST FUnGi
Pathogenic fungi, such as Cryptococcus, Candida, Aspergillus, and Pneumocystis, are considered 
to be four major genera of human fungal pathogens (1). A major host risk factor for development 
of these fungal infections (mycosis) is immunological incompetence, as they are more commonly 
invasive in patients with immunodeficient disorders and those who receive immunosuppressive 
treatments (2, 3).
The innate immune system plays a critical role in host protection against fungi. Specific defects 
in innate immunity, such as neutropenia or functional deficiency of NADPH oxidase, allow hosts to 
develop invasive aspergillosis, candidiasis, and other mycosis (3, 4). For hosts to initiate antifungal 
immune responses, fungi have to be detected by pattern recognition receptors (PRRs). Neutrophils 
and inflammatory macrophages are the first inflammatory cells recruited to the site of infection and 
the major killers of fungi during an early stage of infection. Dendritic cells (DCs) serve an important 
role as professional antigen-presenting cells (APCs) to connect innate and adaptive immunity by 
presenting fungal antigens to prime naïve T cells. As seen in  all the microbial infections, coordinat-
ing innate immunity is the first step to protect hosts from fungal pathogens.
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Defects in the adaptive immune systems are also well-known 
risk factors in fungal infections. Once primed by DCs, T cells 
activate and produce inflammatory cytokines, which further 
recruit innate immune cells to infected sites and facilitate phago-
cytosis (5, 6). B cells are also involved in fungal clearance (7, 8) by 
producing antibodies to opsonize fungal spores, i.e., antibodies 
binds spores and facilitate phagocytosis through stimulating Fc 
Receptor on phagocytes (9, 10).
In this review, we discuss on autophagy and autophagy-related 
processes in host cells during fungal infections as a part of the 
immune responses described above.
AUTOPHAGY
Autophagy is a highly conserved cellular process in eukaryotes 
to maintain cellular homeostasis by supporting cell survival 
and regulating inflammation. Autophagy degrades unnecessary 
or dysfunctional intracellular components, such as abnormal 
proteins, old organelles, and pathogens, and has been widely 
studied in various immune cells, including T cell, B cell, mac-
rophages, DCs, and neutrophils. Autophagy eliminates mito-
chondoria (mitophagy), lipid droplets (lipophagy), ribosomes 
(ribophagy), protein aggregates (aggrephagy), and intracellular 
microbes (xenophagy) (11, 12). Multiple roles for autophagy in 
host defense responses against microbial infections and inflam-
mation have been reported. During a process of autophagy, a 
spherical double-membrane structure, termed autophagosome, 
is formed within a cell. A number of autophagy-related pro-
teins (ATGs), together with other proteins, are involved in the 
process to form autophagosomes; starting from the formation 
of the autophagy initiation complex to elongating autophago-
some membranes. After elongation, the membrane closes and 
autophagosome formation is completed. [Detailed molecular 
information on these steps can be found in excellent review 
articles (13, 14)].
It has been reported that ATGs are associated with human 
autoimmune disorders, cancer, and various infectious diseases 
(15). Single-nucleotide polymorphisms (SNPs) in ATG16L and 
Immunity-related GTPase family M member (IRGM) genes are 
known to increase the risk of Crohn’s disease (16, 17). A SNP of 
IRGM is also associated with susceptibility against Mycobacterium 
tuberculosis infection (18, 19), and SNPs in ATG5 are associated 
with risk of systemic lupus erythematosus (20). UV radiation 
resistance-associated gene (UVRAG) encoding a promoter of the 
autophagy pathway, is monoallelically mutated at a high fre-
quency in human colon cancer (21). Recent study demonstrated 
that Atg5 in neutrophils protects mice from M. tuberculosis infec-
tion in autophagy-independent manner (22). Thus, autophagy 
and autophagy-related genes are suggested to be involved in 
pathogenesis of wide variety of human diseases.
Recent mechanistic studies have shown that autophagy plays 
an immunomodulatory role in both innate and adaptive immune 
responses by selectively targeting signal molecules. For example, 
autophagy inhibits inflammasome activation in macrophages by 
degrading inflammasome assemblies as well as reactive oxygen 
species (ROS)-producing mitochondria, which trigger activation 
of the NLRP3 inflammasome (23, 24). Autophagy is also known to 
be required for neutrophil extracellular trap formation (NETosis) 
(25–27) and immunological training induced by BCG or β-glucan 
in monocytes (28). In T cells, autophagy suppresses T cell receptor-
mediated signaling by degrading BCL10, a downstream molecule 
of the T cell receptor (29). Autophagy also enhances memory B cell 
responses (30, 31). Collectively, these findings implicate autophagy 
in preventing excessive inflammation and protecting the host from 
collateral damage.
LAP AnD AUTOPHAGY
LAP shares some common mechanisms and functions to 
autophagy; and it has been often difficult to separate LAP and 
autophagy. For example, LC3 staining cannot differentiate LAP 
from autophagy, because LC3-associated membranes are formed 
during both processes. LAP formation requires autophagic 
proteins, such as ATG5, ATG7, and LC3; therefore, mice or cells 
lacking one of these proteins cannot undergo both autophagy and 
LAP (32). Initiation of autophagy and LAP also require ROS and 
phosphatidylinositol 3-phosphate synthesis (33, 34); although 
ROS-independent LAP formation was reported in epithelial 
cells (35), suggesting cell type-specific signaling requirements to 
induce autophagy or LAP. It is possible that autophagy in non-
hematopoietic cells is involved in induction of host antifungal 
responses. Similarly to autophagy’s contribution to microbial 
clearance by digesting intracellular pathogens, LAP also plays a 
role in pathogen clearance (36, 37). Despite the similarities, LAP 
is intrinsically distinct from autophagy in forming the LAPosome 
with a single membrane structure (32, 38), the requirement of 
Rubicon and NOX2 (33), and not requiring the autophagy pre-
initiation complex comprised of ULK1/2, FIP200, and ATG13 
(33, 39, 40).
A very recent article demonstrated that LAP is differentiated 
from autophagy using Rubicon-deficient mice (autophagy is 
intact in the mice) (33). Here, we would like to note that previ-
ously published studies using Atg5- or Atg7-deficient mice or 
cells might reflect impacts of impaired LAP as well as autophagy, 
though most of them have been published as “autophagy” studies. 
Therefore, it would be prudent to consider the possible involve-
ment of LAP in previous studies, depending on an experimental 
condition. In this review, we use “LC3-associated cargoes” for 
autophagosomes and LAPosomes if responses in referred articles 
have not identified as autophagy or LAP.
ROLeS OF AUTOPHAGY-ReLATeD 
PROTeinS in FUnGAL inFeCTiOnS
The role of autophagy in antifungal immunity was strongly 
suggested both in mammals and plants (41). Here, we focus 
on autophagy in mammalian cells. Autophagy can be induced 
directly by signaling from fungal-sensing PRRs, and also 
indirectly by pro-inflammatory cytokines, including TNF-α, 
IL-6, IL-1, and IFN-γ (42) during fungal infections. In contrast, 
spores of Aspergillus fumigatus induce LAP based on the study 
using Rubicon-deficient mice (33). LAP is also induced by 
zymosan, a cell-wall component from Saccharomyces cerevisiae 
(33). Therefore, it is possible that other fungi induce LAP. In 
TABLe 1 | impacts of autophagy and LAP on antifungal immunity.
Approaches Findings Reference
A. fumigatus •   Rubicon-, Cybb-, Atg4b-, or Ulk1-deficient 
mice
•   Atg3fl/flLysM-Cre mice, Atg5fl/flLysM-Cre 
mice, Atg7fl/flLysM-Cre mice, Atg12fl/flLysM-
Cre mice, Atg14fl/flLysM-Cre mice,  
Becn1fl/flLysM-Cre mice, Rb1cc1fl/flLysM-
Cre mice
• shRNA for Rubicon
• 3-MA
• Rapamycin
•  A. fumigatus phagocytosed by macrophages induces LAP formation
•  LAP, but not canonical autophagy, is required for clearance of A. fumigatus 
in vitro and in vivo.
• Lack of LAP enhances fungi-induced pulmonary inflammation and granulomas
• SNP in Atg16L does not affect LAP formation
(33)
• 3-MA
• Chloroquine
•  Autophagy suppresses inflammasome-mediated inflammation during  
A. fumigatus infection
•  IL-1R blockade restores autophagy and suppresses fungal growth in CGD mice.
(58)
C. neoformans • RNAi screening
•  siRNA for Atg2a, Atg5, Atg9, Atg12, and 
Map1lc3a (Coding LC3)
• 3-MA
•  Knockdown of Atg5, Atg9a, and Atg12 decreases phagocytosis of  
C. neoformans by macrophages
•  Knockdown of Atg2a, Atg5, Atg9a, Atg12, and LC3 decreases fungal replication 
and escape of C. neoformans
•  Autophagy inhibition by 3-MA reduces phagocytosis, fungal replication, and 
escape of C. neoformans
(54)
• shRNA for Atg5
•  Atg5fl/flLysM-Cre mice
•  Phagocytosed C. neoformans are surrounded by LAP in macrophages
•   Atg5-knock down by shRNA does not affect phagocytosis
•   Atg5-knock down by shRNA or Atg5-knock-out decreases fungicidal activity in 
macrophages 
(50)
C. albicans • shRNA for Atg5
•  Atg5fl/flLysM-Cre mice
•  Phagocytosed C. albicans are surrounded by LC3 in macrophages
•   Atg5-knockdown decreases phagocytosis and fungicidal activity of 
macrophages in vitro
•  Lack of ATG5 in myeloid cells enhances susceptibility of mice against systemic 
C. albicans infection
(50)
•  Atg7fl/flLysM-Cre mice
• 3-MA
• Cohort study of candidemia patients
•  Lack of ATG7 in myeloid cells does not impact on susceptibility of mice against 
systemic C. albicans infection
•  Autophagy inhibition by 3-MA does not affect phagocytosis and fungicidal 
activity against C. albicans in human monocytes
•  SNP in autophagy-related genes does not associate with incidence of 
candidemia
(44)
•  Atg7fl/flLysM-Cre mice
• 3-MA
• Rapamycin
•   C. albicans induces autophagy in macrophages enhances susceptibility against 
systemic C. albicans infection
•  Phagocytosed C. albicans are not surrounded by LC3
•  Autophagy does not affect phagocytosis and fungicidal activity of macrophages 
and neutrophils
•  Autophagic sequestration of A20 enhances NFκB-mediated chemokine 
production in tissue-resident macrophages and increases neutrophil recruitment 
to infected site
• Lack of autophagy in myeloid cells
(43)
•  In vivo imaging using zebra fish • Very few LC3+ phagosome contain C. albicans in vivo (46)
• LC3-deficient BMMs • Dectin-1-induced signaling triggers LAP formation in macrophages
• HK C. albicans induces LAP in macrophages
• Live C. albicans induces modest level of LAP in macrophages
•  LC3-deficiency decreases fungicidal activity of macrophages against  
C. albicans
(45)
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the following subsections and Table 1, we focus on three major 
fungal pathogens: Candida albicans, Cryptococcus neoformans, 
and A. fumigatus to discuss impacts of ATGs on host antifungal 
responses and pathogenesis of fungal infections.
Candida albicans
Several studies have described roles of “autophagy” (or possibly 
LAP) during Candida infection. Candida spores, both live and 
heat-killed, are potent inducers of LC3 puncta formation and 
conversion of LC3-I to LC3-II (43–45). However, it appears 
that live Candida spores are not good at recruiting LC3 around 
internalized spores (43, 45, 46). These results suggest that live 
Candida can induce autophagy (and/or LAP), but direct clearance 
of Candida spores within LC3-associated cargoes is not likely to 
occur. A study by Vyas and colleagues showed that heat-killed C. 
albicans (HKCA) recruited clear LC3-associated cargoes around 
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spores by in vitro observation using the RAW264.7 mouse mac-
rophage cell line. By contrast, when live C. albicans was internal-
ized, LC3-associated cargoes around spores were not very clear 
(45). The result is consistent with an in  vivo study using zebra 
fish, in which live C. albicans rarely recruited significant levels of 
LC3 (46). We also could not detect LC3 signal surrounding live C. 
albicans in both primary macrophages and in a macrophage cell 
line (43). This finding was unexpected, because we speculated that 
Candida spores were engulfed in LC3-positve cargoes and directly 
killed by xenophagy or LAP. The expectation came from previ-
ous reports showing successful recruitment of LC3 to zymosan 
particles (33) and around β-glucan-coated polystyrene beads (45, 
47). However, it is possible that live Candida spores do not expose 
enough β-glucan on their cell surface, while HKCA spores do (45, 
48, 49). Collectively, these studies suggested that direct killing of 
Candida spores within LC3-associated cargoes is not very likely.
Despite the unexpectedly poor engulfment of live Candida in 
LC3-associated cargoes, studies have shown that autophagy (or 
LAP) protects hosts from Candida infections. Lack of ATG5 or 
ATG7 in myeloid cells decreased resistance against systemic C. 
albicans infection (43, 50). The protective role of autophagy (or 
LAP) in Candida infection is partly attributed to enhanced fungi-
cidal activity in host myeloid cells, such as expression of ROS and 
efficiency of phagocytosis (50). Here, we should mention that host 
protection by autophagy or LAP during Candida infection might 
not be always apparent. Smeekens et al. reported no difference in 
survival between wild-type and Atg7 conditional knock-out mye-
loid cells (Atg7 CKO), as well as no difference in phagocytosis and 
killing of Candida (44). Although we found that Atg7 CKO mice 
are more sensitive to systemic Candida infection, we also found no 
difference in phagocytosis and killing of Candida with or without 
ATG7 (43). Reasons for the discrepancy may be experimental 
conditions and differential strain usage of C. albicans. For example, 
Smeekens et al. used a different strain of C. albicans (MYA-3573) 
from others (SC-5314, 18804) (43, 45, 50). We used strain 18804 
and found that ATG7 in myeloid cells plays a protective role in 
hosts without enhancing phagocytosis and killing of Candida (43). 
Same host responses cannot be expected when Candida strains 
are different. For example, published articles suggested distinct 
dectin-1 detection towards two different Candida strains, SC-5314 
and 18804 (51, 52). Taken together, multiple studies suggested 
the involvement of ATG5 and ATG7 in enhancing resistance to 
Candida infection.
As shown in human studies, despite moderate influences on 
pro-inflammatory cytokine production, autophagy genes ATG16L1 
and IRGM have a minor impact on the susceptibility to both 
mucosal and systemic Candida infections (53). Other genes were 
investigated, such as ATG10, ATG16L2, ATG2A, ATG2B, ATG5, 
and ATG9B, but a clear correlation between SNPs of the genes and 
susceptibility to candidemia was not found (44). It was reported 
that an ATG16L human SNP mutant protein (T316A) expressed in 
mice decreases starvation-induced autophagy to 50% with no influ-
ence on zymosan-induced LAP (33). Nevertheless, impacts of these 
SNPs on autophagy and LAP in humans are still elusive. Therefore, 
further studies are needed to understand the consequence of 
autophagy on host immunity against Candida in humans.
Cryptococcus neoformans
Cryptococcus neoformans is an opportunistic fungus. Cryptococcal 
yeasts are encapsulated in polysaccharides and, thus, can evade 
immune detection by hosts. Interestingly, host autophagy sup-
ports intracellular survival and dissemination of C. neoformans 
(54). The report demonstrated that ATGs (ATG5, ATG9a, 
and ATG12) are engaged, but not required, in phagocytosing 
C. neoformans by RAW264.7 macrophages, and the proteins are 
recruited to the vicinity of vacuoles containing C. neoformans 
(54). At a later time point (15 h after infection), ATG2a, ATG5, 
ATG9a, ATG12, and LC3 enhance intracellular replication and 
escape of C. neoformans from vacuoles in macrophages (54). 
Indeed, pharmacological inhibition of autophagy by 3-MA 
reduced levels of Cryptococcus infection (54). Another article 
reported LC3 recruitment to internalized cryptococcal spores; 
and mouse survival from Cryptococcus infection was not altered 
by Atg5 CKO in myeloid cells (50). Nevertheless, the CKO mice 
exhibited reduced lung fungal burdens and protein expression 
of MIP-1α (CCL3), IP-10 (CXCL10), as well as Type-2 cytokines 
IL-4 and IL-13 (50). Expression of IFN-γ and IL-17 did not 
appear to be altered (50). Therefore, further studies are awaited to 
better understand the impact and roles of autophagy (and LAP) 
in Cryptococcus infection.
Aspergillus fumigatus
LC3-II recruitment in A. fumigatus phagosomes was reported 
(55). A recent study using Rubicon-deficient mice clarified that 
LC3 recruitment and clearance of A. fumigatus are mediated by 
LAP, but not by autophagy (33). LAP protects mice from pulmo-
nary aspergillosis by suppressing expression of pro-inflammatory 
cytokine genes and granuloma formation in the lung (33). LAP 
also stabilizes the NOX2 NADPH oxidase complex to produce 
ROS. Macrophages deficient for NOX2 failed to translocate LC3 
to Aspergillus-containing phagosomes, as well as macrophages 
deficient for Beclin1, Rubicon, and ATG7 failed to do so (33). It 
was reported that patients with chronic granulomatous disease 
(CGD), caused by genetic defects in the NADPH oxidase, do not 
recruit LC3 around the Aspergillus-containing phagosomes (55). 
CGD patients indeed show an increased susceptibility to asper-
gillosis (56, 57). In addition, corticosteroid blocks recruitment 
of ATG (55), and its treatment is considered to be a risk factor 
for invasive aspergillosis (57). Another report demonstrated 
that IL-1R blockade protects hosts from invasive aspergil-
losis by increasing LC3 recruitment to Aspergillus-containing 
phagosomes and inhibiting fungal growth (58). In summary, 
LC3-associated cargoes appear to play a critical role in clearance 
of Aspergillus by host cells.
iMMUnOMODULATiOn BY AUTOPHAGY 
DURinG FUnGAL inFeCTiOn
Regulation of inflammasome-Mediated 
immune Responses
Recent studies showed that autophagy controls immune responses 
during fungal infections. Autophagosomes are known to sequester 
FiGURe 1 | Schematic illustration of a mechanism in which autophagy 
enhances antifungal immune responses by sequestering A20. Numbers 
in the figure indicate steps from fungal detection to killing by hosts and 
correspond to the following events: (1) detection of C. albicans by PRRs, such 
as dectin-1 and TLR2, expressed on F4/80hi tissue-resident macrophages; (2) 
autophagy induction and sequestration of A20 in autophagosomes, and A20 
delivery to autophagosomes by p62; (3) IKKγ ubiquitination by sequestering 
A20; (4) enhancement of NFκB activity; (5) increased chemokine production; 
(6) recruitment of neutrophils to infected sites (i.e., where the responding 
tissue-resident macrophages are located); and (7) Killing of fungi by 
neutrophils.
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assembled NLRP3 inflammasome complexes (23, 24), which are 
crucial for host protection against C. albicans and A. fumigatus 
infections (59–61). Another study showed that pharmacological 
inhibition of autophagy by 3-MA or chloroquine enhances inflam-
masome activation and inflammation in mice during A. fumigatus 
infection (58). Increased inflammasome activity was reported in 
monocytes and macrophages from CGD patients (58, 62–64). 
Therefore, autophagy (or LAP) may protect hosts from collat-
eral damage by inflammation through downregulating NLRP3 
inflammasome, which is activated by fungal infections.
nFκB-Mediated immune Responses
We have discussed autophagy-mediated suppression in immune 
responses (23, 29, 65). Yet, autophagy can enhance antifungal 
immune responses in early stages of C. albicans infection by using 
mice conditionally lacking Atg7 in myeloid cells (Atg7 CKO) 
(43) (Table 1; Figure 1). The Atg7 CKO mice showed increased 
fungal burdens in infected sites as a result of reduced neutrophil 
recruitment. This was due to reduced production of neutrophil-
chemoattractants (CXCL1 and CXCL2) by tissue-resident 
macrophages at the site of infection in the absence of Atg7 (43) 
(Figure  1). Unstimulated tissue-resident macrophages express 
high levels of A20, an NFκB inhibitor (66–69). After detec-
tion of C. albicans, autophagy in tissue-resident macrophages 
sequesters A20 and frees NFκB activation from A20-mediated 
inhibition. Autophagy-adaptor protein p62 was demonstrated 
to interact with A20 to carry A20 into LC3-associated cargos 
(43) (Figure 1). Indeed, the lack of ATG7 or p62 increases the 
levels of A20, causing reduction in NFκB activity and chemokine 
production by tissue-resident macrophages (43) (Figure 1). In 
summary, autophagy appears to function in balancing between 
inducing antifungal immunity and controlling excessive 
inflammation.
iMPACTS OF AUTOPHAGY On ADAPTive 
iMMUniTY
Limited amount of autophagy information is available on adap-
tive immune responses against fungal pathogens, but the involve-
ment of autophagy in shaping adaptive immunity to protect 
hosts against fungal infections has been suggested. Autophagy 
enhances survival and functions of T cells (70–72) and B cells 
(73, 74) in various pathological conditions. Autophagic machin-
ery including ATG5 plays an important role in processing and 
presenting extracellular microbial antigens in dendritic cells (75). 
Importantly, LC3-associated cargoes are involved in presenting 
fungal antigen from S. cerevisiae (47). Thus, autophagy appears 
to control antifungal adaptive immune responses via antigen 
presentation by DCs and other APCs. It is still not clear whether 
autophagy in T cells directly controls antifungal immunity.
COnCLUSiOn
Autophagy was initially described as a self-catabolic process, but 
it is now known to play a critical role in clearance of bacterial, 
viral, and parasitic pathogens. Although the role of autophagy 
and ATGs in host defense against fungi had not been made 
clear, recent studies demonstrated the involvement of autophagy 
and ATGs in modulating antifungal immunity. LC3-associated 
cargoes may include fungal spores; but the inclusion cannot be 
always seen, e.g., when live Candida is engulfed. Autophagy and 
LAP generally protect hosts from majority of fungal infections by 
inducing immune responses or by controlling excessive inflam-
mation. There are, however, some exceptions that ATGs promote 
fungal infections. The outcomes of autophagy/LAP in shaping 
host immune responses appear to greatly vary depending on 
species of fungi. Interestingly, previous findings suggested that 
activation of autophagy/LAP by immunosuppressants, such as 
rapamycin or anakinra (IL-1R antagonist), may result in induc-
ing host resistance against fungal infections. It might be possible 
that autophagy-related pathways are targeted for new antifungal 
therapeutics.
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